
GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

